Cardioprotective effect of prior beta-blocker therapy in reducing creatine kinase-MB elevation after coronary intervention - Benefit is extended to improvement in intermediate-term survival

Article; Proceedings Paper

关键词: MYOCARDIAL-INFARCTION;    ATHERECTOMY;    ANGIOPLASTY;    REVASCULARIZATION;    TRANSIENT;    RELEASE;    BALLOON;   

DOI  :  10.1161/01.CIR.102.2.166

来源: SCIE

【 摘 要 】

Background-Both retrospective studies and prospective randomized trials have shown that beta-blockers improve survival and reduce the risk of reinfarction in patients with myocardial infarction. To evaluate whether beta-blockers exert similar protective benefits during and after coronary intervention, we studied the incidence of postprocedure creatine kinase (CK)-MB elevation in patients with or without prior beta-blocker therapy and its effect on intermediate-term (approximate to 1 year) survival. Methods and Results-We prospectively analyzed 1675 consecutive patients undergoing coronary intervention; of these patients, 643 (38.4%) were on beta-blocker therapy before the intervention. The incidence of CK-MB elevation after coronary intervention was 13.2% in patients on beta-blocker therapy before intervention and 22.1% in patients who were not on beta-blockers (P<0.001). Patients with prior beta-blocker therapy had lower persistent/recurrent postprocedure chest pain and lower preprocedure and postprocedure heart rates and mean blood pressures compared with patients who were not on beta-blockers (P<0.001). Multiple linear regression analysis revealed prior beta-blocker therapy as the sole independent factor for lower CK-MB release after coronary intervention. During intermediate-term follow-up at 15+/-3 months, patients on beta-blocker therapy before intervention had lower mortality rates compared with those not on beta-blockers (0.78% versus 1.96%; P=0.04), although the benefit was independent of the reduction in CK-MB release. Conclusions-Our nonrandomized, prospective analysis suggests that prior beta-blocker therapy has a cardioprotective effect in limiting CK-MB release after coronary intervention and that it is associated with a lower mortality at intermediate follow-up.

【 授权许可】

Free